All products sold by Polar Peptides are intended strictly for research use only and are not intended for human consumption, medical use, diagnostic use, or any other unauthorized use
In published preclinical research, BPC 157 has been investigated for effects on inflammation (the bodys immune response to injury), soft-tissue healing, and protection of the gastrointestinal lining
The main concerns are local injection reactions, infection risk if sterility is breached, and misuse (e.g
Coli Risk On March 23, 2017, Pro Sports Club of Bellevue, WA issued a recall of 36,957 20/20 Life Styles Yogurt Peanut Crunch bars because they have the potential to be contaminated with Escherichia coli O157:H7
Researchers studying gastrointestinal effects have used both acute (single-dose) and chronic (7-14 day) protocols, with efficacy observed in both paradigms
Its still an experimental synthetic peptide with limited human study results